Oxybutynin

• Overactive Bladder
• Urge Incontinence
• Neurogenic Bladder

Oxybutynin is an antimuscarinic (anticholinergic) medication used to treat overactive bladder (OAB) symptoms including urinary urgency, frequency, and urge incontinence. Available in multiple formulations, it has been a mainstay of OAB treatment for decades.

Mechanism of Action

Oxybutynin works through multiple mechanisms:

• Muscarinic receptor blockade: Competitively inhibits M1 and M3 receptors in the detrusor muscle
• Direct smooth muscle relaxation: Independent antispasmodic effect on bladder muscle
• Local anesthetic effect: Minor contribution to activity

By blocking acetylcholine from binding to muscarinic receptors in the bladder, oxybutynin reduces involuntary detrusor muscle contractions, increasing bladder capacity and decreasing urgency.

Available Formulations

Oral Immediate-Release:

• Tablets: 5 mg
• Syrup: 5 mg/5 mL

Oral Extended-Release (Ditropan XL):

• Tablets: 5 mg, 10 mg, 15 mg

Transdermal Patch (Oxytrol):

• 3.9 mg/day patch (applied twice weekly)
• Available OTC for women

Topical Gel (Gelnique):

• 10% gel (1 g sachets or pump)

Medical Uses

FDA-Approved Indications:

• Overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency
• Neurogenic bladder (detrusor overactivity)
• Pediatric bladder dysfunction (immediate-release, ≥5 years)

Extended-release and transdermal formulations may have fewer anticholinergic side effects than immediate-release.

Dosing Guidelines

Immediate-Release:

• Adults: 5 mg two to three times daily; max 5 mg four times daily
• Elderly: 2.5 mg two to three times daily initially
• Children ≥5 years: 5 mg two to three times daily

Extended-Release:

• Adults: Start 5-10 mg once daily; may increase by 5 mg weekly
• Maximum: 30 mg once daily
• Swallow whole; do not crush or chew

Transdermal Patch:

• One patch (3.9 mg/day) applied twice weekly (every 3-4 days)
• Apply to dry, intact skin on abdomen, hip, or buttock
• Rotate application sites

Topical Gel:

• 1 g (100 mg) applied once daily to thigh, abdomen, upper arm, or shoulder

Important Safety Information

Contraindications:

• Urinary retention
• Gastric retention
• Uncontrolled narrow-angle glaucoma
• Known hypersensitivity to oxybutynin

Warnings and Precautions:

• CNS effects: Somnolence, confusion, hallucinations (especially in elderly)
• Heat prostration: Reduced sweating can cause overheating in hot environments
• GI motility: Use with caution in GI obstructive disorders
• Cardiac effects: Use with caution in patients with arrhythmias
• Myasthenia gravis: May worsen condition

Cognitive Concerns: Anticholinergic medications are associated with cognitive decline in elderly patients. Consider alternatives with lower anticholinergic burden.

Drug Interactions

• Other anticholinergics: Additive anticholinergic effects
• CNS depressants: Increased sedation
• CYP3A4 inhibitors: May increase oxybutynin levels
• Cholinesterase inhibitors: Antagonistic effects
• Potassium chloride solid oral forms: Increased GI lesion risk

Special Populations

• Elderly: Start with lower doses; increased sensitivity to anticholinergic effects
• Hepatic Impairment: Use with caution
• Renal Impairment: Use with caution in severe impairment
• Pregnancy: Category B; use only if needed
• Lactation: May suppress lactation; appears in breast milk